Navient (NAVI) Q3 2025 Earnings Transcript

Motley Fool Transcribing, The Motley Fool

Tue, April 21, 2026 astatine 10:41 AM CDT

Image source: The Motley Fool.

Wednesday, October 29, 2025 astatine 8 a.m. ET

• Chief Executive Officer — Brenton L. Saunders

• Chief Financial Officer — Osama Eldessouky

• Chief Medical Officer and Head of R&D — Yehia Hashad

Brenton L. Saunders: Thank you, George, and bully greeting to everyone joining america today. I'm going to supply an overview of our awesome 3rd 4th show and talk to however our strategy and patience is paying off. Sam volition spell deeper connected the financials and update 2025 guidance, and I'll adjacent with a look astatine products driving maturation and opportunity. I'd similar to convey my 13,000 colleagues astir the satellite upfront due to the fact that without their committedness and content successful what we tin execute together, we'd beryllium stuck successful neutral. Instead, we're delivering connected the imaginativeness we laid retired successful 2023.

6% changeless currency gross maturation was erstwhile again fueled by a basal concern motor that continues to hump and the dependable instauration of innovative products crossed categories. Pharmaceuticals was a standout, acknowledgment to $84 cardinal successful Miebo revenue. Miebo maturation helped bolster our broad adust oculus portfolio, which is beforehand and halfway for oculus attraction professionals, patients and consumers. Effective selling has besides meant much surgeons implanting enVista intraocular lenses, helping thrust 27% changeless currency gross maturation successful premium IOLs. Our loaded and differentiated pipeline volition beryllium connected afloat show successful conscionable a fewer weeks astatine Investor Day. Importantly, the pipeline products we'll item aren't aspirational. These are objective signifier programs with anticipated launches implicit the adjacent respective years.

Every portion of our astir 3-year travel since I returned arsenic CEO has been aligned to 1 oregon much of 3 categories you've each go acquainted with: selling excellence, operational excellence and disruptive innovation. Those aren't optional. They are imperatives. While our travel is obscurity adjacent complete, fixed however acold we've come, we've introduced a 4th category, fiscal excellence. This is our accidental to present sustained profitable maturation that reflects our existent potential. We'll amusement you what that looks similar astatine Investor Day erstwhile we stock our 3-year plan. We've reached a pivotal constituent successful our travel to becoming the champion oculus wellness company.

Being the champion means elevating the modular of attraction successful oculus health, which is wherefore our pipeline is filled with products that person the imaginable to beryllium genuinely disruptive and reset expectations for oculus attraction professionals, patients and consumers. You'll larn overmuch much astir the subject down our pipeline and marketplace accidental astatine Investor Day, but here's a sneak peek. In consumer, caller formulations of LUMIFY, PreserVision and Blink Triple Care volition marque class leaders adjacent much appealing and are expected to unlock importantly larger audiences. In Pharmaceuticals, next-generation lifitegrast would alteration the adust oculus illness attraction paradigm.